Luye Pharma’s new antidepressant drug Ansufaxine Hydrochloride Sustained-Release Tablets was accepted by CDE
Time of Update: 2021-06-16
On June 10th, Luye Pharmaceutical Group announced that its self-developed Chinese chemical drug Class 1 new drug Ansufacine Hydrochloride Sustained-Release Tablets (LY03005) has been officially accepted by the Drug Evaluation Center of the China National Medical Products Administration .
Luye Pharma's Class 1 new drug Ansufaxine Hydrochloride Sustained-Release Tablets reached the preset end point in Phase III clinical trials
Time of Update: 2021-04-27
The China Phase III clinical trial of LY03005 is a multi-center, randomized, double-blind, placebo-controlled study to verify the effectiveness and safety of LY03005 in the treatment of depression.
Announcement on the approval of L-amateline hydrochloride as a new variety of food additives and the expanded use of 3 food additives
Time of Update: 2020-06-30
in accordance with the Provisions of the Food Safety Law of the People's Republic of China and the Measures for the Administration of New Varieties of Food Additives, and approved, L-amateag glycine hydrochloride as a new variety of food
Pro Pharma's new drug, antatory hydrochloride, gets FDA approval
Time of Update: 2020-06-08
the main manufacturers of amphetamine-release tablets in the United States are PAR, TEVA, etc., and there is currently no product spree of the dosage form ( marketed.
Enhua pharmaceutical heavy new drug Remifentanil Hydrochloride for Injection approval completed
Time of Update: 2020-04-03
According to the information on the website of CFDA on October 13, the review status of remifentanil hydrochloride for injection, a heavy new drug of Enhua Pharmaceutical Co., Ltd., was changed to "approved - to be certified".
The project of "industrialization of new anesthetic drugs hydromorphone hydrochloride
Time of Update: 2020-04-03
On March 31, 2014, the company received 16 million yuan of relevant state subsidies.
The production of "loratrak hydrochloride", a new anti-tumor drug of Kangchen Pharmaceutical Co., Ltd., has been declared
Time of Update: 2020-04-03
Loratrek hydrochloride for injection, a national first-class anti-cancer drug developed by Kangchen Pharmaceutical Development Co., Ltd., is a non classical structure of folic acid
The second domestic new hepatitis C drug clopevir hydrochloride capsule was approved for marketing
Time of Update: 2020-02-12
Recently, the State Drug Administration approved the listing of clopevir hydrochloride capsule (trade name: kailivi) (Code: kw-136), a class 1 innovative drug of Beijing
Priority review of the 4th new indication of Zhengda Tianqing androtinib hydrochloride capsule
Time of Update: 2020-01-19
Wen Jie winter On January 17, CDE announced a new batch of applications to be included in the priority review and approval list, including the listing application for the fourth new indication of Zhengda Tianqing androtinib hydrochloride capsule.
Huahai Pharmaceutical Co., Ltd.: new specification supplement application of doxycycline
Time of Update: 2019-06-20
On June 19, Huahai pharmaceutical announced that the company's supplementary application for the new specifications of doxycycline hydrochloride sustained-release tablets declared
Ensatinib hydrochloride, a new drug of Beida pharmaceutical, was included in the priority review procedure by the State Food and Drug Administration
Time of Update: 2019-02-25
Beida pharmaceutical has just released a notice that its new drug, ensatinib hydrochloride, was included in the publicity list of the proposed priority review varieties by the drug review center of the National Drug Administration (nmpa) on February 15, 2019.
New specification supplement application of doxycycline hydrochloride sustained release tablets of Huahai Pharmaceutical Co., Ltd. approved by FDA
Time of Update: 2019-02-22
The original drug of doxycycline hydrochloride sustained-release tablets was developed by mayneparma company, and was approved to be listed in the United States as early as 2008.
Shanghai Pharmaceutical Institute's "national class 1.1 new drug Antofloxacin hydrochloride
Time of Update: 2018-01-09
Source: Dream pursuing tour January 8, 2018, 2017 National Science and technology award conference was held in Beijing
Led by Yang Yushe, researcher of Shanghai
Materials and tablets of cytarabine hydrochloride valine ester, a new chemical drug of Shenyang Pharmaceutical University, obtained clinical approval
Time of Update: 2017-01-07
Recently, the raw materials and tablets (acceptance No.: cxhl1502498, cxhl1502499 and cxhl1502500) of the new chemical drug cytarabine hydrochloride valine ester, developed by Shenyang Pharmaceutical University, have obtained the approval documents for clinical trials.
Hydroxypiperone hydrochloride, a class 1.1 new drug of Huahai pharmaceutical, has obtained
Time of Update: 2015-08-06
The company announced that 1.1 new antidepressant mepyridone hydrochloride was approved for clinical trial, which is another important progress made in the process of industrial upgrading, adding impetus to the medium and long-term development of the company.
LVYE pharmaceutical 1.1 new chemical drug anshufaxin hydrochloride sustained release tablets (ly03005) approved for clinical use
Time of Update: 2015-07-03
Recently, LVYE Pharmaceutical Group Co., Ltd. has obtained the approval documents of phase II and phase III clinical trials issued by China food and Drug Administration (CFDA) for the new 1.1 chemical drug slow release tablets (ly03005).
Levocetirizine hydrochloride granules, a class 5 new drug of Kangzhi pharmaceutical, has obtained the production approval
Time of Update: 2015-06-16
In the afternoon of June 16, Kangzhi pharmaceutical released a notice that the company recently received the registration approval document of levocetirizine hydrochloride granules
Fuan pharmaceutical's class 3.1 new high blood pressure drug, Nabil hydrochloride, will enter
Time of Update: 2015-01-11
According to the Research Report of Guolian securities, in 2012, the global sales of Nabil hydrochloride reached US $1 billion, which is also a potential 1 billion product in the domestic market.
Enhua pharmaceutical heavy new drug remifentanil hydrochloride for injection is approved within one month
Time of Update: 2014-09-11
People from the company told DZH news that the approved production of remifentanil is a high probability event.